IP Library Assignment 057474/0770
Patent Assignment
Reel/Frame 057474/0770

Seventh Amended and Restated Intellectual Property Security Agreement

Recorded: 2021-09-12 Pages: 11
Assignors
AKEBIA THERAPEUTICS, INC.
Executed: 2021-09-03
KERYX BIOPHARMACEUTICALS, INC.
Executed: 2021-09-03
Assignee
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD, C/O BEAUFORT HOUSE, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties (29)
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application: 15/553,348 →
Publication: US 2018/0071243
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application: 16/154,268 →
Publication: US 2019/0269645
Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients
Application: 16/216,772 →
Publication: US 2019/0307791
Ferric Citrate Dosage Forms
Application: 16/376,907 →
Publication: US 2020/0215019
Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide
Application: 16/815,472 →
Publication: US 2021/0032186
Ferric Citrate Dosage Forms
Application: 16/894,121 →
Publication: US 2020/0297689
Method of Treating Chronic Kidney Disease
Application: 17/119,554 →
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 17/141,765 →
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 17/350,267 →
Publication: US 2022/0144872
Methods for Treating Renal Failure
Patent: 5,753,706 →
Application: 08/794,328 →
Pharmaceutical-Grade Ferric Citrate
Patent: 6,903,235 →
Application: 10/682,045 →
Publication: US 2005/0080283
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 7,767,851 →
Application: 11/206,981 →
Publication: US 2006/0020026
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Method of Making Same
Patent: 8,093,423 →
Application: 12/064,058 →
Publication: US 2008/0274210
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Method of Making Same
Patent: 8,299,298 →
Application: 13/289,048 →
Publication: US 2012/0114747
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,338,642 →
Application: 12/711,679 →
Publication: US 2010/0217025
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,609,896 →
Application: 13/672,900 →
Publication: US 2013/0079537
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,754,257 →
Application: 13/661,558 →
Publication: US 2013/0052261
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,754,258 →
Application: 14/011,291 →
Publication: US 2013/0345460
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,846,976 →
Application: 14/011,357 →
Publication: US 2014/0018420
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,901,349 →
Application: 14/011,325 →
Publication: US 2014/0011872
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,050,316 →
Application: 14/306,756 →
Publication: US 2014/0309298
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,328,133 →
Application: 14/502,774 →
Publication: US 2015/0232495
Ferric Citrate Dosage Forms
Patent: 9,387,191 →
Application: 13/255,326 →
Publication: US 2012/0115945
Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide
Patent: 9,624,155 →
Application: 14/184,062 →
Publication: US 2015/0025138
Method of Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification
Patent: 9,750,715 →
Application: 12/162,558 →
Publication: US 2009/0326060
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,757,416 →
Application: 14/701,933 →
Publication: US 2016/0095878
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,913,821 →
Application: 15/143,987 →
Publication: US 2017/0095441
Ferric Citrate Dosage Forms
Application: 15/159,008 →
Publication: US 2016/0263075
Method of Treating Chronic Kidney Disease
Application: 15/814,767 →
Publication: US 2018/0133191
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 19, 1999
From: HSU, CHEN H.
To: HSU, MARLENE
Reel/Frame 010095/0789 →
Assignment of Assignor's Interest Oct 8, 2003
From: HSIAO, YIH-MING; CHIU, HSUEH-HUNG; WANG, HSIU-CHING; CHANG, YU-CHEN
To: PANION & BF BIOTECH INC.
Reel/Frame 014599/0176 →
Assignment of Assignor's Interest May 16, 2007
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH, INC.
Reel/Frame 019302/0403 →
License Jan 11, 2008
From: PANION & BF BIOTECH, INC.
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 020353/0121 →
Assignment of Assignor's Interest Mar 13, 2008
From: HSU, MARLENE
To: HSU, CHEN HSING
Reel/Frame 020645/0145 →
Assignment of Assignor's Interest Sep 26, 2008
From: CHAN, KEITH; TOWN, WINSTON
To: GLOBOASIA, LLC
Reel/Frame 021589/0785 →
Assignment of Assignor's Interest Dec 6, 2012
From: CHAN, KEITH; TOWN, WINSTON
To: GLOBOASIA, LLC
Reel/Frame 029417/0419 →
Nunc Pro Tunc Assignment Dec 6, 2012
From: GLOBOASIA, LLC
To: PANION & BF BIOTECH, INC.
Reel/Frame 029417/0502 →
Assignment of Assignor's Interest Dec 6, 2012
From: GLOBOASIA, LLC
To: PANION & BF BIOTECH, INC.
Reel/Frame 029417/0373 →
Nunc Pro Tunc Assignment Dec 6, 2012
From: GLOBOASIA, LLC
To: PANION & BF BIOTECH, INC.
Reel/Frame 029417/0593 →
Assignment of Assignor's Interest Dec 6, 2012
From: CHAN, KEITH; TOWN, WINSTON
To: GLOBOASIA, LLC
Reel/Frame 029417/0254 →
Corrective Assignment to Correct the Conveyance Type Previously Recorded on Reel 029417 Frame 0373. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment with the Effective Date of August 18, 2006. Dec 10, 2012
From: GLOBOASIA, LLC
To: PANION & BF BIOTECH, INC.
Reel/Frame 029436/0054 →
Corrective Assignment to Correct the Error Entering the Application Number and Re-Record to Remove U.S. Application No. 13672900 Previously Recorded on Reel 029417 Frame 0419. Assignor(S) Hereby Confirms the Assignment to U.S. Application No. 13661558. Jan 7, 2013
From: CHAN, KEITH; TOWN, WINSTON
To: GLOBOASIA, LLC
Reel/Frame 029575/0184 →
Corrective Assignment to Correct the Error Entering the Application Number and Re-Record to Remove U.S. Application No. 13672900 Previously Recorded on Reel 029417 Frame 0502. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment with the Effective Date of August 18, 2006 to U.S. Application No. 13661558. Jan 7, 2013
From: GLOBOASIA, LLC
To: PANION & BF BIOTECH, INC.
Reel/Frame 029575/0196 →
Assignment of Assignor's Interest Jan 28, 2013
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH, INC.
Reel/Frame 029705/0165 →
Assignment of Assignor's Interest Jan 28, 2013
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH, INC.
Reel/Frame 029705/0290 →
Assignment of Assignor's Interest Jan 22, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032021/0708 →
Assignment of Assignor's Interest Jan 22, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032021/0598 →
Nunc Pro Tunc Assignment Jan 22, 2014
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 032022/0001 →
Assignment of Assignor's Interest Jan 22, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032021/0338 →
Assignment of Assignor's Interest Jan 22, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032021/0830 →
Assignment of Assignor's Interest Feb 6, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032164/0940 →
Assignment of Assignor's Interest Feb 6, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032164/0916 →
Assignment of Assignor's Interest Feb 6, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032161/0024 →
Assignment of Assignor's Interest Feb 6, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032164/0891 →